Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Irofulven plus Xeloda evaluated in phase I trial in advanced solid tumors

June 10, 2002

Coenzyme A-peptide conjugates for use in cancer

June 10, 2002

Pierre Fabre presents new protein prenyltransferase inhibitors

June 10, 2002

PI-88 plus Taxotere to be evaluated in phase I trial

June 7, 2002

Phase Ib trial evaluating CA4P in combination with carboplatin in advanced solid tumors

June 7, 2002

Phase II dose of orally active MEK inhibitor selected from phase I studies

June 7, 2002

Acceptable safety and PK profile emerges from ongoing phase I trial of EKB-569

June 7, 2002

A phase I trial in patients with advanced solid tumors shows the safety and efficacy of BMS-214662

June 7, 2002

Phase III trial of RSR-13 in brain metastases continues following interim review

June 7, 2002

AES-14 reduces severe mucositis in acute radiation model

June 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026